Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care

Chief Marketing Officer at Carevive Systems
21 de Jul de 2015
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care
1 de 61

Mais conteúdo relacionado

Mais procurados

Rehab a.o'rourkeRehab a.o'rourke
Rehab a.o'rourkeandreafletcher
Treatment m.feinbergTreatment m.feinberg
Treatment m.feinbergandreafletcher
Setting Up for Survivorship SuccessSetting Up for Survivorship Success
Setting Up for Survivorship SuccessAcademy of Oncology Nurse Navigators, Inc.
Survivorship Program ExamplesSurvivorship Program Examples
Survivorship Program ExamplesAcademy of Oncology Nurse Navigators, Inc.
2013 Cancer Survivorship Conference at Jefferson University Hospitals2013 Cancer Survivorship Conference at Jefferson University Hospitals
2013 Cancer Survivorship Conference at Jefferson University Hospitalsjeffersonhospital
Let's Talk LymphedemaLet's Talk Lymphedema
Let's Talk LymphedemaCanadian Cancer Survivor Network

Mais procurados(20)

Similar a Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care

The Importance of Cancer Rehabilitation The Importance of Cancer Rehabilitation
The Importance of Cancer Rehabilitation Canadian Cancer Survivor Network
Integrative OncologyIntegrative Oncology
Integrative OncologyCara Feldman-Hunt
Brian Sick, M.D.Brian Sick, M.D.
Brian Sick, M.D.smsherman
Jefferson University Hospitals' April 2013 Cancer Survivorship Conference Pre...Jefferson University Hospitals' April 2013 Cancer Survivorship Conference Pre...
Jefferson University Hospitals' April 2013 Cancer Survivorship Conference Pre...jeffersonhospital
Support for breast_cancer_survivorsSupport for breast_cancer_survivors
Support for breast_cancer_survivorsSelf Employed (Business)
Developing a national strategy for research into cancer survivorship in the U...Developing a national strategy for research into cancer survivorship in the U...
Developing a national strategy for research into cancer survivorship in the U...Irish Cancer Society

Similar a Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care (20)

Mais de Carevive

Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...
Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...Carevive
AMCCBS Virtual2021 Conference Takeaways Part 2AMCCBS Virtual2021 Conference Takeaways Part 2
AMCCBS Virtual 2021 Conference Takeaways Part 2Carevive
AMCCBS Virtual2021 Conference Takeaways Part 1AMCCBS Virtual2021 Conference Takeaways Part 1
AMCCBS Virtual 2021 Conference Takeaways Part 1Carevive
What’s New in Acute Myelogenous Leukemia?What’s New in Acute Myelogenous Leukemia?
What’s New in Acute Myelogenous Leukemia?Carevive
Geriatric Assessment in Older Patients with Acute Myelogenous Leukemia: Treat...Geriatric Assessment in Older Patients with Acute Myelogenous Leukemia: Treat...
Geriatric Assessment in Older Patients with Acute Myelogenous Leukemia: Treat...Carevive
Improving Management of Non-Metastatic Castration-Resistant Prostate Cancer (...Improving Management of Non-Metastatic Castration-Resistant Prostate Cancer (...
Improving Management of Non-Metastatic Castration-Resistant Prostate Cancer (...Carevive

Último

OVERVIEW OF ANTIMICROBIAL STEWARDSHIPOVERVIEW OF ANTIMICROBIAL STEWARDSHIP
OVERVIEW OF ANTIMICROBIAL STEWARDSHIPTanveerRehman4
Free radicals in Neurodegenerative diseases- Parkinsonism.pptxFree radicals in Neurodegenerative diseases- Parkinsonism.pptx
Free radicals in Neurodegenerative diseases- Parkinsonism.pptxE Poovarasan
MCU.pptxMCU.pptx
MCU.pptxDr. Dheeraj Kumar
ROJoson PEP Talk: Breast Cancer Awareness Month - 2023ROJoson PEP Talk: Breast Cancer Awareness Month - 2023
ROJoson PEP Talk: Breast Cancer Awareness Month - 2023Reynaldo Joson
Orthodontic ExtrusionOrthodontic Extrusion
Orthodontic ExtrusionAbdulsammad Habeeb
duty roster in nursing.pptxduty roster in nursing.pptx
duty roster in nursing.pptxManeera Gulzar

Último(20)

Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Led Care

Notas do Editor

  1. Between 1971 and 2007 the number of adult cancer survivors has increased dramatically…there are currently over 12 million adult cancer survivors in the US. On January 1, 2008, in the United States there were approximately 11,957,599 men and women alive who had a history of cancer of all sites -- 5,505,862 men and 6,451,737 women New citation = Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
  2. DATA SOURCES Incidence dataIncidence data derive from population-based cancer registries. These may cover entire national populations but more often cover smaller, subnational areas, and, particularly in developing countries, only major cities. The most important source of information on cancer incidence is the successive volumes of Cancer Incidence in Five Continents CI5 [1,2]. Incidence data are generally associated with some delay as they require time to be compiled and published, but recent information can often be found in routine reports from the registries themselves, commonly available via their websites. While the quality of information from most of the developing countries might not be of sufficient quality, this information is still of unique importance as it often remains the only relatively unbiaised source of information available on the profile of cancer.Population-based cancer registries can also produce survival statistics by following up their vital status of cancer patients. Survival probabilities [3] can be used to estimate mortality from incidence in the absence of mortality data, and to estimate cancer prevalence. Mortality dataMortality statistics are collected and made available by the WHO [4]. Their advantages are national coverage and long-term availability, although not all datasets are of the same quality. For some countries, coverage of the population is incomplete, so that the mortality rates produced are implausibly low, and in others, the quality of cause of death information is poor. While almost all the Europen and American countries have comprehensive death registration systems, most African and Asian countries (including the populous countries of Nigeria, India and Indonesia) do not. For the GLOBOCAN 2008 estimates, we benefitted from the provisional estimates of the age- and sex-specific deaths from cancer (of all types) for 2008 in each country of the world. Prevalence data1-, 3-, and 5-year prevalence is estimated from incidence estimates (for 2008) and observed survival by cancer and age group provided by cancer registries worldwide (see below). Prevalence is presented for the adult population only (ages 15 and over), and is available both as numbers and as proportions per 100,000 persons. Disability-adjusted life years (DALY)A detailed description of the data sources and the methods of estimation used to obtain the parameters required to calculate DALYs have been described elsewhere [6]. In brief, the following country- and cancer-specific sets of estimates were used in the computation of DALYs: (1) population data (source UN, see below), (2) incidence and mortality estimates from GLOBOCAN 2008, (3) estimates of the proportion cured and treated, (4) time intervals of distinct disease phases including duration of diagnosis and treatment, time to cure and to death, (5) standard life expectancy tables, and (6) disability weights. DALYs were estimated for each cancer site by sex and country. Population dataNational population estimates for 2008 were extracted from the United Nation (UN) population division, the 2008 revision [5]. The geographical definition of the regions follows the rules as defined by the UN (see the Population dictionary option). These estimates may differ slightly (especially for older age groups) from those prepared by national authorities. ReferencesParkin, D.M., Whelan, S.L., Ferlay, J., and Storm, H. Cancer Incidence in Five Continents, Vol. I to VIII. IARC CancerBase No. 7, Lyon, 2005. Curado. M. P., Edwards, B., Shin. H.R., Storm. H., Ferlay. J., Heanue. M. and Boyle. P., eds (2007) Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publications No. 160, Lyon, IARC. Sankaranarayanan R. Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB, Shin HR, Shanta V, Woo ZH, Martin N, Sumitsawan Y, Sriplung H, Barboza AO, Eser S, Nene BM, Suwanrungruang K, Jayalekshmi P, Dikshit R, Wabinga H, Esteban DB, Laudico A, Bhurgri Y, Bah E, Al-Hamdan N. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010 Feb;11(2):165-73. World Health Organisation (WHO) Databank, Geneva, Switzerland. WHO Statistical Information System http://www.who.int/whosis United Nations, Population division. World Population Prospects, the 2008 revision. (http://www.un.org/, last accessed on 08/11/2009). Isabelle Soerjomataram, Joannie Lortet-Tieulent, Jacques Ferlay, David Forman, Colin Mathers, Donald Maxwell Parkin and Freddie Bray. Estimating and validating disability-adjusted life years at the global level: a framework for cancer. BMC Medical Research Methodology. in press METHODS The methods used to estimate the country specific burden of cancer are similar to those used in the GLOBOCAN 2002 study [1] and have been described in detail elsewhere [2]. In summary, the most recent disease rates available were applied to the corresponding population of the country in 2008. For GLOBOCAN 2008, the degree of delay in the available data was taken into account by computing predictions of the national incidence and mortality rates to the year 2008, wherever possible. Although historical trends will not always hold in the future, predictions based on relatively linear trend patterns have been shown empirically to be reasonably accurate, particularly in the short-term. Where the availability of annual data was minimal - commonly between 5 and 10 years - simple time-linear models were fitted to these data to predict incidence and mortality for 2008 [3]. Where data series spanning at least 15 years were available, predictions based on age-period-cohort modeling were utilised [4].Sex- and cancer-specific predictions of the national incidence and mortality rates were performed when at least 50 cancer cases or cancer deaths (all ages) were recorded per year for short-term predictions, and when at least 100 cancer cases or deaths (all ages) were recorded per 5-year period for NORDPRED [4]. Otherwise, the rates for 2008 were estimated as the annual average for the most recent 5-year period available.
  3. Physical problems (86%): Energy, concentration, sexual dysfunction, neuropathy, pain were most highly endorsed Emotional concerns (93%): Fear of recurrence, depression, grief/identity issues, concerns about family members risk Financial & job related concerns (58%): 70% of those in school reported school-related problems 40% experienced employment issues Debt issues (33%); insurance issues (21%)
  4. Quality is highly variable, few pathways Care is not well coordinated Work force shortages will worsen
  5. Cancer surveillance Only 55.0% of n = 2297 colorectal cancer survivors received recommended colonoscopies (Salloum et al., 2012) 38% of older (> 65) BC survivors did not receive annual mammography after diagnosis (Schapira et al., 2000) Late effect surveillance Tanvetyanon T. Cancer. 2005;103:237-241. 2. Yee EF, et al. J Gen Intern Med. 2007;22:1305-1310. 3. Chen Z, et al. Cancer. 2005;104:1520-1530. Supportive care/rehab/psychosocial care Cancer rehabilitation services 66% of 244 oncology outpatients screened positive for functional problems Only 2 rehabilitation referrals generated 6% of clinician notes referred to functional problems Psychosocial care - Need to look up this literature
  6. Quality is highly variable, few pathways Care is not well coordinated Work force shortages will worsen
  7. CH Jagielski poster at Biennial 2010; Salner et al poster at APOS 2012. All RCTs were UK-based models except Koinberg et al (Sweden) ALL RCTs were in breast cancer except Moore et al (which was combined telephone and phone for LUNG cancer) All RCTS were telephone based except for Moore and Koinberg
  8. There are several models of care that have been piloted across the country and I outlined them here for you….
  9. Community hospital approaches: 1) Lancaster General Hospital (PA) Nurse navigator model Introduce survivorship concept at diagnosis Prospectively prepare treatment summary (TS) Provide TS & SCP at end of treatment visit Social worker telephone follow-up Address addt’l concerns, connect w/resources 2) Minnesota Oncology CNS/nurse navigator model Visits at baseline, mid-cycle, end of treatment (TS/SCP at EOT)